RxDoctor Payments Data

Sean Leng, MD

Geriatric Medicine · Baltimore, MDNPI 1952346546

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $275,240 of the $411,954 with a category attached, or 66.8%. GSK accounts for 83.1% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $145,514 and has fallen 72.5% since, to $39,967 in 2025. Among geriatric medicine clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$411,954in general payments, 2019–2025

Across 474 payments — averaging $869.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$342K
  • Sanofi Pasteur Inc.$69K
  • Sanofi-aventis U.S. LLC$15
$389,359in research payments, 2019–2025

Across 10 payments — averaging $38,936 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi Pasteur Inc.$389K

What the payments were for

  • Consulting fees$33,2038%
  • Speaking & faculty fees$275,24067%
  • Travel & lodging$93,59223%
  • Food & beverage$9,9052%
  • Education$150%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK437$342,471
Sanofi Pasteur Inc.36$69,468
Sanofi-aventis U.S. LLC1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$411,954 in reported general payments places this provider in the 95th percentile of 112 geriatric medicine providers in Maryland.

See all geriatric medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$6,870
Medicare patients
49
Services billed
70

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other geriatric medicine in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →